0000899243-19-015014.txt : 20190529 0000899243-19-015014.hdr.sgml : 20190529 20190529162215 ACCESSION NUMBER: 0000899243-19-015014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190524 FILED AS OF DATE: 20190529 DATE AS OF CHANGE: 20190529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chin Mark CENTRAL INDEX KEY: 0001734389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38503 FILM NUMBER: 19862273 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE, MAYFAIR CITY: LONDON STATE: X0 ZIP: W1J 6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-24 0 0001659323 Iterum Therapeutics plc ITRM 0001734389 Chin Mark C/O ITERUM THERAPEUTICS PLC, BLK 2 FL. 3, HARCOURT CENTRE, HARCOURT ST. DUBLIN L2 2 IRELAND 1 0 0 0 Ordinary Shares 2019-05-24 4 M 0 6154 A 6154 D Ordinary Shares 1089903 I By Arix Bioscience Holdings Ltd. Restricted Stock Units 2019-05-24 4 M 0 6154 0.00 D Ordinary Shares 6154 0 D Restricted stock units converted into ordinary shares on a one-for-one basis upon vesting of the units. The reporting person is an Investment Director for Arix Bioscience Holdings Ltd. On May 24, 2018, the reporting person was granted an award of 6,154 restricted stock units, which vested on May 24, 2019. /s/ Mark Chin 2019-05-27